What is being bought
RF Healthcare is not the contracting authority. Check the original source for eligibility, lots, deadlines and instructions. Inclusion does not guarantee that a supplier can participate.
View published sourceProcurement intelligence
Betsi Cadwaladr University Health Board
RF Healthcare is not the contracting authority. Check the original source for eligibility, lots, deadlines and instructions. Inclusion does not guarantee that a supplier can participate.
View published sourceOne procurement, a connected history
This is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales. Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027. The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded. (WA Ref:171237)
Read this source noticeThis is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales. Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027. The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded. (WA Ref:171236)
Read this source noticeThis is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales. Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027. The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded. (WA Ref:171235)
Read this source noticeThe service is to review those prescribed edoxaban in primary care with a view to changing them to a more cost effective alternative.
Read this source noticeThis is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales. Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027. The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded. (WA Ref:170700)
Read this source noticeThis is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales. Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027. The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded. (WA Ref:170698)
Read this source noticeThis is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales. Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027. The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded. (WA Ref:170697)
Read this source noticeThis is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales. Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027. The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded. (WA Ref:170692)
Read this source noticeThis is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales. Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027. The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded. (WA Ref:170689)
Read this source notice